Number of the records: 1  

Osimertinib with or without Chemotherapy in EGFR-Mutated Advanced NSCLC

  1. TitleOsimertinib with or without Chemotherapy in EGFR-Mutated Advanced NSCLC
    Author infoPlanchard D., Andrasina I. ... [et al.]
    Co-authors Andrašina Igor 1955-
    Corporation Redakcia Onkológia
    NoteN Engl J Med. 2023 Nov 23;389(21):1935-1948
    Sign.C 3069
    Source Onkológia. - ISSN 1336-8176. - Bratislava : SOLEN , 2023 . - Roč. 18, č. 5 (2023), s. 388-389
    MeSH Subject karcinóm pľúc, nemalobunkový : farmakoterapia
    skúšanie klinické, fáza III, ako téma
    farmakoterapia kombinovaná
    prežívanie bez progresie
    Form, Genre abstrakt v angličtine
    Subj. Headings karcinóm pľúc nemalobunkový s mutáciami EGFR * osimertinib
    LanguageEnglish
    CountrySlovak Republic
    Document kindRozpis článkov z periodík
    DatabaseARTICLES
    article

    article

Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.